KNOWLEDGE BANK

Interviews

Peering into the Future

Co-founder and CTO, BrainSightAI
Dr Rimjhim Agrawal Cofounder and CTO of BrainSightAI has expertise in neuroscience and machine learning to solve complex challenges in this field Her PhD in psychiatry coupled with a strong focus on AI in neuroscience drove early research into utilising AI to gain deeper insights into complex psychiatric disorders such as schizophrenia and OCD Her research has resulted in significant contributions...

Articles

3D Printing

The pharmaceutical industry is undergoing a profound transformation driven by advanced manufacturing technologies that challenge conventional models of drug development clinical supply and production Among these innovations threedimensional D printing and more specifically semisolid extrusion SSE printing is emerging as a highly promising approach for the manufacture of clinical batches

Research Insights

SARS-CoV2 Evokes Structural Brain Changes Resulting in Declined Executive Function

Coronavirus disease is caused by the severe acute respiratory syndrome coronavirus which was first identified in Wuhan China rapidly spreading around the world

Case Studies

Diagnostics - Stable Aqueous Horseradish Peroxidase

Challenge The main use of Horseradish peroxidise HRP is in diagnostic applications to produce a detectable signal indicating presence of a molecular target Typically HRP is used in conjugates with antibodies the antibody to recognise the molecular target an

Techno Trends

Zai Lab Introduced Breakthrough Repotrectinib Treatment for Advanced Solid Tumours in China

Zai Lab has introduced a new drug called repotrectinib to help patients with advanced solid tumours that have specific gene mutations NTRK gene fusions and have already been treated with other targeted therapies

White Papers

Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches

In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS

TOP ARTICLES

1

Natural Polymers and Fibers in Drug Delivery

Dr. Meghraj V. Suryawanshi

Dr. Meghraj V. Suryawanshi is an Associate Professor and Co-Founder of Sandip Institute of Pharmaceutical Sciences. He holds M.Pharm, MBA, PDCR, and Ph.D. degrees. With over 7 years of research experience and 4 years in teaching, his expertise lies in polymer science, novel drug delivery systems (NDDS), and intellectual property rights (IPR). Dr. Suryawanshi has authored more than 55 publications, 8 books, and holds several patents. He actively leads innovative pharmaceutical research with a strong focus on translational impact.

Akshata Yashwant Patne

Akshata Yashwant Patne is a pharmaceutical nanotechnology expert with over 3 years of experience in clinical research, drug delivery, and AI-driven therapeutics. She has led nanoparticle-based studies, published peer-reviewed articles, and actively mentors students, combining science, innovation, and leadership across academia, research, and global scientific communities.

2

Advancing Automation and Digitalization in the Industrial Microbiology Workflow

Brad Grobler

Brad is Head of Biomonitoring Strategic Initiatives, which includes development and execution of  the Digital strategy in Robotics & Automation, eBusiness, Informatics and the Biomonitoring Ecosystem. Throughout his 10 years at the company, Brad has been engaged in Commercial, Operation and Strategy with regional and global focus.

 

3

Meet scientist Daria Donati

Daria Donati

Daria’s work is ongoing. Her role at Cytiva involves identifying new and innovative technologies that can help in the development of therapeutics. This means building partnerships, improving manufacturing processes and, ultimately, getting life- saving drugs to the people who need them most.

 

4

Design of Self-antibacterial and Biocompatible Titanium Surfaces for Biomedical Applications

Lalit M. Pandey

Lalit M Pandey is an Associate Professor at the Department of Biosciences and Bioengineering, IIT Guwahati. His main research interests include biointerfaces and biomaterials, biochemical engineering, and environmental biotechnology. He has published over hundred research articles in international journals and serves on the editorial board of six international journals. He is serving as Associate Editor in Frontiers in Bioengineering and Biotechnology. He has co-edited three books. He is a life member of the International Association of Engineers (IAENG), the National Academy of Sciences (NASI), the Indian Institute of Chemical Engineers (IIChE), the Biotech Research Society, India (BRSI), and Nano and Molecular Society (India) and serves as a reviewer for several peer-reviewed journals.

 

5

Artificial Intelligence - A current and future tool to learn chemical sciences

Ruchi Bharti

Ruchi Bharti received her M.Sc. from Patna University, in organic chemistry. PhD from National Institute of Technology Patna (NIT Patna), in 2012. There she worked on the development of new organocatalysts and their utilization in the synthesis of diverse heterocyclic compounds via multimulticomponent reactions. In 2017, she enrolled as assistant professor at R. P Sharma Institute of Technology, Since 2018, she joined Department of Chemistry, University Institute of Sciences, Chandigarh University, Punjab as Assistant Professor. Her recent research work is focused on the functionalisation of diverse heterocycles, multicomponent reactions, organocatalysis and their related biological and medicinal applications.

 

press releasesRead more...

AI, Forecasting, Insights and Analytics for Smarter Decisions in Pharma

Forecasting insights and analytics is a strategic decisionmaking function within global product strategy and commercial departments in pharmaceutical companies Unlike operational or salesfocused functions

Merck Opens BioReliance® Facility in Darmstadt to Support Drug Product Release in Europe

Merck a leading science and technology company today opened a new million BioReliance testing facility at its global headquarters in Darmstadt Germany The facility expands access to commercial

GSK-developed TB vaccine candidate progresses toward global access with new manufacturing agreement

GSK welcomes the agreement reached between the Gates Medical Research Institute and Serum Institute of India SII for the manufacture of the MASE tuberculosis vaccine candidate pending successful Phase trial outcomes

Harbour BioMed and Kelun-Biotech Announce NMPA Approval of IND Application for HBM7575/SKB575 for the Treatment of Asthma

Harbour BioMed HKEX a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology oncology and other areas and KelunBiotech

The R&S IMAGER from Rohde & Schwarz uses millimeter wave imaging to inspect the quality of packaged goods in real time

With the new RS IMAGER Rohde Schwarz is expanding its realtime millimeter wave inspection portfolio The RS IMAGER uses innovative imaging technology to penetrate materials with invisible

PDA Advanced Parenteral Therapeutics & Quality Summit 2026 to Spotlight ATMP Innovation, Regulatory Trends, and Quality Excellence in Asia

The PDA Advanced Parenteral Therapeutics Quality Summit organized by PDA Asia Pacific in collaboration with the PDA Taiwan Chapter will gather leading experts from across the pharmaceutical biotechnology and regulatory sectors at the ILLUME Hotel Taipei on September

EventsRead more...

16 - 19

Jul 2026

Bio Asia Taiwan 2026

Taipei Nangang Exhibition Cent...

20 - 22

Jul 2026

6th mRNA-Based Therapeutics Summit

The Westin Boston Seaport Dist...

20 - 22

Jul 2026

24 - 25

Jul 2026

26 - 30

Jul 2026

ADLM 2026

Anaheim, CA USA

27 - 28

Jul 2026

27 - 28

Jul 2026

27 - 28

Jul 2026

LATEST NEWSRead more...

LTR Pharma Signs Definitive U.S. Commercial Agreement with Shed

LTR Pharma has signed a definitive commercial agreement with Shed to support the planned US commercialisation of ROXUS

Excalipoint Therapeutics Partners with DP Technology to Develop AI Platform for TCE Drug Discovery

Excalipoint Therapeutics has entered into a strategic partnership with DP Technology to codevelop a proprietary artificial intelligence AIpowered platform for the discovery of Tcell engagers TCEs and multispecific antibodies

Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals

Angelini Pharma has completed the acquisition of Catalyst Pharmaceuticals strengthening its position in brain health and rare diseases while establishing a commercial presence in the United States

Samsung Bioepis and Organon Expand Biosimilar Commercialisation Agreement in Australia

Samsung Bioepis and Organon have expanded their Development and Commercialisation Agreement to introduce an additional biosimilar product in Australia through Organon ANZ

Telix Opens Australia's First Integrated Radiopharmaceutical Facility in Melbourne

Telix has officially opened a new multimilliondollar radiopharmaceutical research manufacturing and treatment facility in Melbourne to strengthen Australias capabilities in cancer diagnosis and treatment

Insilico Medicine and Bora Pharmaceuticals Form Strategic Alliance to Advance AI-Driven Drug Development

Insilico Medicine has announced a proposed strategic alliance with Bora Pharmaceuticals to combine artificial intelligence AIdriven drug discovery with global drug development and manufacturing capabilities